ID   PD-L1.3
AC   CVCL_B7F9
SY   PDL1.3; PD-L1.3.1
DR   Wikidata; Q112930295
RX   Patent=US9637546;
RX   Patent=US9896507;
RX   PubMed=20587542;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
RX   Patent=US9637546;
RA   Olive D., Serriari N.-E., Nunes J.A., Ghiotto M.;
RT   "PD-1 antibodies and PD-L1 antibodies and uses thereof.";
RL   Patent number US9637546, 02-May-2017.
//
RX   Patent=US9896507;
RA   Olive D., Gondois-Rey F., Serriari N.-E., Pastor S.;
RT   "BTLA antibodies and uses thereof.";
RL   Patent number US9896507, 20-Feb-2018.
//
RX   PubMed=20587542; DOI=10.1093/intimm/dxq049;
RA   Ghiotto M., Gauthier L., Serriari N.-E., Pastor S., Truneh A.,
RA   Nunes J.A., Olive D.;
RT   "PD-L1 and PD-L2 differ in their molecular mechanisms of interaction
RT   with PD-1.";
RL   Int. Immunol. 22:651-660(2010).
//